Study Details
A Study of IMAB362 in Japanese Subjects with Locally Advanced or Metastatic Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma
Clinicaltrials.gov ID
Astellas Study ID
8951-CL-0104
EudraCT ID
N/A
Condition
Stomach or Esophageal Cancer
Phase
Phase 1
Age
20 years - N/A
Sex
Female & Male
Product
zolbetuximab
Type
Interventional
Trial Dates
May 2018 - Mar 2020
Masking
None (Open Label)
Enrollment number
18
A Phase 1 Open-label Study of IMAB362 in Japanese Subjects with Locally Advanced or Metastatic Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma
Study summary
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A Study of IMAB362 in Japanese Subjects with Locally Advanced or Metastatic Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma? Contact us by filling our your information to the right and we’ll respond to you.
Locations
Site JP00001
Kashiwa, Japan